Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial
References (34)
- et al.
Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters
Hepatology
(1995) - et al.
Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function
Hepatology
(1995) - et al.
Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure
Kidney Int
(1986) - et al.
Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage
J Hepatol
(1995) - et al.
Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement
Gastroenterology
(1994) - et al.
Management of ascites
J Gastroenterol Hepatol
(1992) Refractory ascites
Semin Liver Dis
(1993)- et al.
Pharmacotherapy of ascites associated with cirrhosis
Drugs
(1992) - et al.
Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites
N Engl J Med
(1989) - et al.
Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites
N Engl J Med
(1991)
Should porto-systemic shunt be reconsidered in the treatment of intractable ascites in cirrhosis?
Arch Surg
TIPSS for treatment of refractory ascites: a pilot study
Hepatology
Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt
Radiology
The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites
N Engl J Med
Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites
Ann Intern Med
The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function
Clin Sci
Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol
J Hepatol
Cited by (401)
New Indications for TIPSs: What Do We Know So Far?
2023, Journal of Clinical and Experimental HepatologyNorth American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension
2022, Clinical Gastroenterology and HepatologyCurrent treatment options of refractory ascites in liver cirrhosis – A systematic review and meta-analysis
2022, Digestive and Liver DiseaseA Prospective Study of Prevalence and Predictors of Cirrhotic Cardiomyopathy and Its Role in Development of Hepatorenal Syndrome
2022, Journal of Clinical and Experimental HepatologyDirect intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyond Budd-Chiari syndrome
2022, Clinics and Research in Hepatology and Gastroenterology
- 1
The following persons participated in the French Group of Clinicians: Didier Lebrec, Nathalie Giuily, Antoine Hadengue, Valérie Vilgrain, Richard Moreau, Adrián Gadano, Claudine Lassen, Jean-Pierre Benhamou, Serge Erlinger, Jacques Bernuau, Alain Chemtob, Françoise Degos, François Durand, Annie Elman, Sophie Hillaire, Patrick Marcellin, Thierry Soupison, Florence Vachiery, Dominique Valla, Marie-Pierre Vullierme, and Song Yang, (INSERM U-24, Service d'Hépatologie and Service de Radiologie, Hôpital Beaujon, Clichy), Thierry Poynard, (Groupe Hospitalier de la Pitié-Salpétrière, Paris), Philippe Sogni, (Hôpital Cochin, Paris), Dominique Roulot, (Hôpital Avicenne, Bobigny), Jean-Luc Saraux, (Hôpital Emile Roux, Eaubonne), Jean-Pierre Capron, Dominique Capron, (Centre Hospitalier Universitaire, Amiens), Emmanuel Carteret (Groupe Médical Saint Rémi, Reims), Abdeslam Bental, (Centre Hospitalier, Abbeville) and Yves Ajavon, (Hôpital Jean Verdier, Bondy). The following persons participated in the Group of Biolgoists: Daniel Bichet, (Hôpital du Sacré-Coeur, Montréal, Canada), Stéphane Cailmail (INSERM U-24, Clichy), Kathleen Laborde, (Hôpital Necker, Paris) and Eric Pussard (Centre Hospitalier de Bicêtre, Le Kremlin-Bicêtre).